Kimia Biosciences share price
You have to be logged in to add this to Watchlist.- ₹41.76(20.00%)February 13, 2026 15:25:53 PM IST
- NSE
- BSE
- Vol : 91.64 K (NSE + BSE)Last 20 day avg : 10.70 K
Kimia Biosciences is trading 20.00% upper at Rs 41.76 as compared to its last closing price. Kimia Biosciences has been trading in the price range of 39.00 & 33.60. Kimia Biosciences has given 2.50% in this year & 10.48% in the last 5 days. Kimia Biosciences has TTM P/E ratio 20.79 as compared to the sector P/E of 23.66.The company posted a net profit of 1.02 Crores in its last quarter.Listed peers of Kimia Biosciences include Sun Pharmaceutical Industries (-0.97%), Divi's Laboratories (-0.13%), Torrent Pharmaceuticals (-0.18%).The Mutual Fund holding in Kimia Biosciences was at 0.38% in 31 Dec 2025. The MF holding has decreased from the last quarter. The FII holding in Kimia Biosciences was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Feb 15, 2026, 01:56 AM UTC
- BetaMedium volatility1.06Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry3.95The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BHigher than historical values16.52The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- PEG RatioIndicates undervaluation0.42The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Neutral | 1,698.00 | -0.97 | 4,07,849.42 | 33.61 | 5.35 | 0.99 | 0.50 |
| Divi's Laboratories | Neutral | 6,180.45 | -0.13 | 1,64,071.53 | 74.87 | 10.97 | 0.48 | 0.01 |
| Torrent Pharmaceuticals | Bullish | 4,074.05 | -0.18 | 1,37,562.02 | 69.51 | 17.65 | 0.81 | 17.62 |
| Dr Reddy's Laboratories | Bullish | 1,268.00 | -0.51 | 1,05,788.83 | 17.99 | 3.03 | 0.65 | 2.34 |
| Cipla | Bearish | 1,331.70 | 0.16 | 1,07,570.97 | 20.38 | 3.44 | 0.98 | 0.81 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-02-14 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-09-04 | Final Dividend & A.G.M. |
| 2025-08-29 | A.G.M. & Others |
| 2025-08-14 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE285U01025
- BSE Code530313
- NSE Code
Kimia Biosciences is trading at 41.76 as on Fri Feb 13 2026 09:55:53. This is 20.00% upper as compared to its previous closing price of 34.80.
The market capitalization of Kimia Biosciences is 197.58 Cr as on Fri Feb 13 2026 09:55:53.
The 52 wk high for Kimia Biosciences is 86.85 whereas the 52 wk low is 26.09
Kimia Biosciences can be analyzed on the following key metrics -
- TTM P/E: 20.79
- Sector P/E: 23.66
- Dividend Yield: 0.00%
- D/E ratio: 3.11
Kimia Biosciences reported a net profit of 9.61 Cr in 2025.
The Mutual Fund Shareholding was 0.38% at the end of 31 Dec 2025.